Chronic lymphocytic leukaemia (CLL) is the most common form of adult leukaemia in the Western world.1,2 In the UK, CLL accounts for 1% of all new cancer cases and 38% of all leukaemias.3
The new CLL Knowledge Centre provides healthcare professionals with important information to aid the treatment and management of patients with the disease. Content is arranged within three main areas: ‘Disease awareness’, ‘Events’ and ‘Resources’.
Healthcare professionals will find sections on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment, management, an upcoming events calendar and useful external links.
We are conducting a short survey regarding educational needs of healthcare professionals in relation to chronic lymphocytic leukaemia (CLL) and other haematological malignancies.
The questions will take approximately 5-10 minutes of your time to complete and your input will be much appreciated.
Hallek M. Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Blood. 2013 Nov 28;122(23):3723-34.
Gibson J, Iland HJ, Larsen SR, Brown CM, Joshua DE. Leukaemias into the 21st century. Part 2: the chronic leukaemias. Intern Med J. 2013 May;43(5):484-94.
Prostate cancer is the third most frequently diagnosed cancer in Europe and the most common cancer among European men,1 making it a major cause of morbidity. Risk factors for prostate cancer include, increasing age, genetic susceptibility, glucose intolerance and environmental factors.2
The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403. EUCAN fact sheet. Estimated incidence, mortality & prevalence, 2012.
Tewari R, Rajender S, Natu SM et al. Diet, obesity, and prostate health: are we missing the link? J Androl 2012;33:763-776.
The Anti-Infectives Knowledge Network – Clostridium difficile infection (AIKN-CDI), an initiative by Astellas Pharma EMEA, shares the expertise and experience of thought leaders in the area of anti-infectives.
This educational resource is sponsored by Astellas Pharma EMEA and assembles the expertise of key thinkers in the area of anti-infectives with a focus on invasive fungal infections.
Ensure you return often to make the most of regular updates to this resource including congress highlights, industry reports, policy changes, clinical guidelines and downloadable materials (e.g. presentation slides) from major medical events.
The congresses section has been updated with a report from the ‘Integrating Critical Care and Haemato-oncology’ meeting held in Berlin, November 2014. Experts gathered to share opinion and debate on the changing nature of care for haemato-oncology patients requiring critical care. View this report for free here.
Elizabeth Hadley, Consultant Respiratory and General Physician, Barking, Havering and Redbridge Hospitals University NHS Trust, London, UK
Case History A 24-year-old woman was seen in the chest clinic with an eight-week history of cough with occasional sputum, fever and malaise. She also described an occasional nagging pain under her sternum and palpitations.
Respiratory Medicine & Allergy: Non granuloma interstitial lung disease
Elizabeth Hadley,Consultant Respiratory and General Physician, Barking, Havering and Redbridge Hospitals University NHS Trust, London, UK Boris Lams,Consultant Respiratory Physicians, Guy's and St Thomas' NHS Foundation Trust, London, UK
Case History A 49-year-old Cypriot woman was referred with a nine-month history of gradually increasing breathlessness and a dry cough. She was breathless at 100 yards.
7 days ago -
Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix.
OBJECTIVE: To demonstrate the safety and efficacy of up to 5 years of degarelix treatment and the effects of crossing over from leuprolide to degarelix in the extension phase of a phase III pivotal ...
Chronic lymphocytic leukaemia is the most common leukaemia in the Western world and generally..
... affects older populations. These updated ESMO Clinical Practice Guidelines present the latest information on CLL including the diagnosis and molecular biology of CLL and treatment strategies for early and advanced disease.
Diffuse large B-cell lymphoma is relatively common and represents 30%–58% of..
... non-Hodgkin’s lymphomas. The updated ESMO Clinical Practice Guidelines provide information on the current management of diffuse large B-cell lymphoma including recommendations for screening and diagnosis, staging and risk assessment and stage-matched therapeutic strategies including specific recommendations for young and elderly, low-to-high risk subgroups.
"This article is intended for primary care clinicians, oncologists, urologists, nurses, pharmacists, and other clinicians who care for men with prostate cancer. The goal of this activity is to provide...
Bedwetting resource receives mobile transformation
The Bedwetting Knowledge Centre has been given a new mobile-friendly look and feel. Users can now easily access FREE information and resources on nocturnal enuresis via their mobile and tablet devices.